Market Cap (In TWD)
1.37 Billion
Revenue (In TWD)
315.98 Million
Net Income (In TWD)
-10.68 Million
Avg. Volume
133.69 Thousand
- Currency
- TWD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 14.0-20.9
- PE
- -
- EPS
- -
- Beta Value
- 0.843
- ISIN
- TW0004186002
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- -
- Employee Count
- -
- Website
- https://www.biotest.com.tw
- Ipo Date
- 2012-11-27
- Details
- Taiwan Advance Bio-Pharmaceutical Inc. operates in the biotechnology industry in China Germany, USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, India, Pakistan, and internationally. The company provides food safety diagnostic testing kits; ELISA, rapid, and chemical test kits customization, and food safety lab establishment consultation services; and manufactures monoclonal and polyclonal antibody products. It also offers abused drugs rapid tests; provides cell banking services for newborn and adult stem cells storage; and operates drug testing center for urine drug test, hair drug test, and identification of drug abuse. The company was founded in 1989 and is based in New Taipei City, Taiwan.
More Stocks
-
INVESTInvestors House Oyj
INVEST
-
009160SIMPAC Inc.
009160
-
PBBKPB Bankshares, Inc.
PBBK
-
SATOF
-
BABP
-
FATBBFAT Brands Inc.
FATBB
-
JMHLY
-
DHBKDoha Bank Q.P.S.C.
DHBK